Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Marks

Showing results (1091-1100 of 1,105) with videos related to

Pageof 111
Sort By:
Journal of Substance Use and Addiction Treatment|November 27, 2025
The impact of the communities that HEAL intervention on the provision of jail-based medication for opioid use disorder & linkage programs at release: Results from a randomized, wait-list controlled trialCarrie B Oser, Joel G Sprunger, Tim Hunt, et al.
Nature Immunology|June 5, 2019
Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppressionQingsong Hu, Youqiong Ye, Li-Chuan Chan, et al.
Drug and Alcohol Dependence|April 16, 2024
Effect of the Communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trialLaShawn Glasgow, Christian Douglas, Joel G Sprunger, et al.
Cancer Research|April 6, 2007
Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancerSimon A Gayther, Honglin Song, Susan J Ramus, et al.
Leukemia|August 1, 2015
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter surveyR Zeiser, A Burchert, C Lengerke, et al.
American Journal of Public Health|October 10, 2024
Effect of the Communities That HEAL Intervention on Overdose Education and Naloxone Distribution: A Cluster-Randomized, Wait-List Controlled TrialPatricia R Freeman, Alexander Y Walley, T John Winhusen, et al.
Cancer Cell|November 18, 2022
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohortsSiri H Strand, Belén Rivero-Gutiérrez, Kathleen E Houlahan, et al.
Nature Genetics|June 10, 2022
Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancerEsther H Lips, Tapsi Kumar, Anargyros Megalios, et al.
Cancer Research|March 12, 2009
Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancerJoellen M Schildkraut, Ellen L Goode, Merlise A Clyde, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2010
Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association ConsortiumCatherine M Phelan, Ya-Yu Tsai, Ellen L Goode, et al.
Pageof 111

Showing results (1091-1100 of 1,105) with videos related to

Sort By:
Pageof 111
Journal of Substance Use and Addiction Treatment|November 27, 2025
The impact of the communities that HEAL intervention on the provision of jail-based medication for opioid use disorder & linkage programs at release: Results from a randomized, wait-list controlled trialCarrie B Oser, Joel G Sprunger, Tim Hunt, et al.
Nature Immunology|June 5, 2019
Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppressionQingsong Hu, Youqiong Ye, Li-Chuan Chan, et al.
Drug and Alcohol Dependence|April 16, 2024
Effect of the Communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trialLaShawn Glasgow, Christian Douglas, Joel G Sprunger, et al.
Cancer Research|April 6, 2007
Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancerSimon A Gayther, Honglin Song, Susan J Ramus, et al.
Leukemia|August 1, 2015
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter surveyR Zeiser, A Burchert, C Lengerke, et al.
American Journal of Public Health|October 10, 2024
Effect of the Communities That HEAL Intervention on Overdose Education and Naloxone Distribution: A Cluster-Randomized, Wait-List Controlled TrialPatricia R Freeman, Alexander Y Walley, T John Winhusen, et al.
Cancer Cell|November 18, 2022
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohortsSiri H Strand, Belén Rivero-Gutiérrez, Kathleen E Houlahan, et al.
Nature Genetics|June 10, 2022
Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancerEsther H Lips, Tapsi Kumar, Anargyros Megalios, et al.
Cancer Research|March 12, 2009
Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancerJoellen M Schildkraut, Ellen L Goode, Merlise A Clyde, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2010
Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association ConsortiumCatherine M Phelan, Ya-Yu Tsai, Ellen L Goode, et al.
Pageof 111